Cargando…
Impaired therapeutic efficacy of bone marrow cells from post-myocardial infarction patients in the TIME and LateTIME clinical trials
Implantation of bone marrow-derived cells (BMCs) into mouse hearts post-myocardial infarction (MI) limits cardiac functional decline. However, clinical trials of post-MI BMC therapy have yielded conflicting results. While most laboratory experiments use healthy BMC donor mice, clinical trials use po...
Autores principales: | Wang, Xiaoyin, Chacon, Lourdes I., Derakhshandeh, Ronak, Rodriguez, Hilda J., Han, Daniel D., Kostyushev, Dmitry S., Henry, Timothy D., Traverse, Jay H., Moyé, Lem, Simari, Robert D., Taylor, Doris A., Springer, Matthew L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7446972/ https://www.ncbi.nlm.nih.gov/pubmed/32841277 http://dx.doi.org/10.1371/journal.pone.0237401 |
Ejemplares similares
-
Overexpression of Nitric Oxide Synthase Restores Circulating Angiogenic Cell Function in Patients With Coronary Artery Disease: Implications for Autologous Cell Therapy for Myocardial Infarction
por: Chen, Qiumei, et al.
Publicado: (2016) -
Cell therapy for refractory angina: time for more ACTion
por: Psaltis, Peter J, et al.
Publicado: (2011) -
One Minute of Marijuana Secondhand Smoke Exposure Substantially Impairs Vascular Endothelial Function
por: Wang, Xiaoyin, et al.
Publicado: (2016) -
Author Correction: Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
por: Jokerst, Jesse V., et al.
Publicado: (2018) -
Circulating Biomarkers to Identify Responders in Cardiac Cell therapy
por: Jokerst, Jesse V., et al.
Publicado: (2017)